A small early study found that four weeks of low-dose rapamycin improved blood flow in the brains of healthy middle-aged adults carrying the APOE4 gene variant, with the strongest effect seen in women.
Low-dose rapamycin improves brain blood flow in middle-aged adults at Alzheimer's risk
A small early study found that four weeks of low-dose rapamycin improved blood flow in the brains of healthy middle-aged adults carrying the APOE4 gene variant, with the strongest effect seen in women.
Vertenflow · Public domain · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.